Company news
Aclaris Therapeutics, Inc. news in 2022
Aclaris Therapeutics, Inc.'s news releases, calls and decks from 2022, newest first.
Aclaris Therapeutics and Pediatrix Therapeutics Announce License Agreement for ATI-1777 in Greater China
November 28, 2022
Aclaris Therapeutics Announces Key Leadership Transitions
November 21, 2022
Aclaris Therapeutics to Participate in Two November Healthcare Investor Conferences
November 9, 2022
Aclaris Therapeutics Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
November 7, 2022
Aclaris Therapeutics Appoints Robert Doody as Vice President, Investor Relations
September 26, 2022
Aclaris Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
August 29, 2022
Aclaris Therapeutics Announces Patent License Agreement with Lilly for Alopecia Areata
August 24, 2022
Aclaris Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
August 2, 2022
Aclaris Therapeutics Expands Leadership Team
July 31, 2022
Aclaris Therapeutics to Participate in the Jefferies Healthcare Conference
May 31, 2022
Aclaris Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
May 15, 2022
Aclaris Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update
May 9, 2022
Aclaris Therapeutics to Participate in the LifeSci Partners Immunology & Inflammation Symposium
May 2, 2022
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
February 23, 2022
Aclaris Therapeutics to Participate in the SVB Leerink Virtual 11th Annual Global Healthcare Conference
February 1, 2022
Aclaris Therapeutics Provides R&D Update
January 10, 2022
Decks in 2022
- Technical Presentation (November 2022)
Technical · 6 slides · Nov 8, 2022